https://clinicaltrials.gov/ct2/show/NCT04100642?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F10%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Phase I Clinical Study of Hemay808
DESCRIPTION:
Condition: Safety Issues
Interventions: Drug: Hemay808; Drug: Placebo
Sponsor: Tianjin Hemay Pharmaceutical Co.,Ltd
Enrolling by invitation
CLINICALTRIALS.GOV IDENTIFIER:
NCT04100642
FIRST POSTED:
Tue, 24 Sep 2019 12:00:00 EDT
LAST UPDATE POSTED:
09/24/19 06:52AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04100642?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F10%2F2019&lupd_d=14&sort=nwst
